Literature DB >> 20369834

Characterization of aziridinylbenzoquinone DNA cross-links by liquid chromatography-infrared multiphoton dissociation-mass spectrometry.

Sarah E Pierce1, Lynn J Guziec, Frank S Guziec, Jennifer S Brodbelt.   

Abstract

DNA cross-linking was evaluated by liquid chromatography-tandem mass spectrometry to determine the relative cross-linking abilities of two aziridinylbenzoquinones. Reactivities of RH1 (2,5-diaziridinyl-3-[hydroxymethyl]-6-methyl-1,4-benzoquinone), a clinically studied antitumor cross-linking agent, and an analogue containing a phenyl group (2,5-diaziridinyl-3-[hydroxymethyl]-6-phenyl-1,4-benzoquinone, PhRH1) rather than a methyl group were compared. The bulky phenyl substituent was added to determine the impact of steric hindrance on the formation of cross-links within a double helical structure. Cross-links formed by RH1 and PhRH1 were observed at 5'-dGNC sites as well as 5'-dGAAC/dGTTC sites. RH1 was more effective at forming cross-links than PhRH1 for a variety of duplexes. Infrared multiphoton dissociation (IRMPD) and collision-induced dissociation results confirmed the presence and the location of the cross-links within the duplexes, and IRMPD was used to identify the dissociation pathways of the cross-linked duplexes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20369834      PMCID: PMC2891125          DOI: 10.1021/tx1000738

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  54 in total

1.  NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA.

Authors:  O Y Fedoroff; M Salazar; H Han; V V Chemeris; S M Kerwin; L H Hurley
Journal:  Biochemistry       Date:  1998-09-08       Impact factor: 3.162

Review 2.  Electrospray ionization mass spectrometry of oligonucleotide complexes with drugs, metals, and proteins.

Authors:  J L Beck; M L Colgrave; S F Ralph; M M Sheil
Journal:  Mass Spectrom Rev       Date:  2001 Mar-Apr       Impact factor: 10.946

3.  The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.

Authors:  Jeanne Fourie; Curtis J Oleschuk; Frank Guziec; Lynn Guziec; Derek J Fiterman; Cielo Monterrosa; Asher Begleiter
Journal:  Cancer Chemother Pharmacol       Date:  2001-11-24       Impact factor: 3.333

4.  Efficient DNA alkylation by a pyrrole-imidazole CBI conjugate with an indole linker: sequence-specific alkylation with nine-base-pair recognition.

Authors:  Toshikazu Bando; Shunta Sasaki; Masafumi Minoshima; Chikara Dohno; Ken-ichi Shinohara; Akihiko Narita; Hiroshi Sugiyama
Journal:  Bioconjug Chem       Date:  2006 May-Jun       Impact factor: 4.774

Review 5.  Recent developments in ruthenium anticancer drugs.

Authors:  Aviva Levina; Anannya Mitra; Peter A Lay
Journal:  Metallomics       Date:  2009-08-13       Impact factor: 4.526

Review 6.  Prodrug strategies in cancer therapy.

Authors:  W A Denny
Journal:  Eur J Med Chem       Date:  2001 Jul-Aug       Impact factor: 6.514

7.  Adenine-containing DNA-DNA cross-links of antitumor nitrogen mustards.

Authors:  Shawn Balcome; Soobong Park; Danaè R Quirk Dorr; Lucy Hafner; Laura Phillips; Natalia Tretyakova
Journal:  Chem Res Toxicol       Date:  2004-07       Impact factor: 3.739

8.  Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity.

Authors:  Jeanne Fourie; Frank Guziec; Lynn Guziec; Cielo Monterrosa; Derek J Fiterman; Asher Begleiter
Journal:  Cancer Chemother Pharmacol       Date:  2003-11-12       Impact factor: 3.333

9.  Structure elucidation of DNA interstrand cross-link by a combination of nuclease P1 digestion with mass spectrometry.

Authors:  Yuesong Wang; Yinsheng Wang
Journal:  Anal Chem       Date:  2003-11-15       Impact factor: 6.986

10.  DNA alkylation and interstrand cross-linking by treosulfan.

Authors:  J A Hartley; C C O'Hare; J Baumgart
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

View more
  4 in total

Review 1.  Photodissociation mass spectrometry: new tools for characterization of biological molecules.

Authors:  Jennifer S Brodbelt
Journal:  Chem Soc Rev       Date:  2014-01-30       Impact factor: 54.564

Review 2.  Tandem mass spectrometry for characterization of covalent adducts of DNA with anticancer therapeutics.

Authors:  Catherine Silvestri; Jennifer S Brodbelt
Journal:  Mass Spectrom Rev       Date:  2012-11-13       Impact factor: 10.946

3.  Comparison of MS/MS methods for characterization of DNA/cisplatin adducts.

Authors:  Zhe Xu; Jared B Shaw; Jennifer S Brodbelt
Journal:  J Am Soc Mass Spectrom       Date:  2012-12-20       Impact factor: 3.109

Review 4.  Hypoxia-active nanoparticles used in tumor theranostic.

Authors:  Yaqin Wang; Wenting Shang; Meng Niu; Jie Tian; Ke Xu
Journal:  Int J Nanomedicine       Date:  2019-05-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.